Renal cell cancer clinical trials are a therapeutic indication where the PSI project management philosophy has been proven effective time and again. The PSI clinical team is highly qualified and has the right skills to manage site relationships and support investigators to meet enrollment goals.
PSI has widespread experience in enrolling patients for oncology studies, with the vast majority of trials completing on-time or ahead of schedule patient enrollment. Recognizing the challenges in these type of clinical trials, PSI selects highly-experienced professional investigators who can pool a sufficient number of patients from the target population in advance.
The enrollment graphs below features studies that PSI recently conducted and reflects the actual versus planned timelines for clinical trials, reflecting PSI’s consistent performance.
For more information on PSI’s clinical trial experience in this therapeutic area, please contact us.
